Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Conditions:   Adenocarcinoma of the Prostate;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate CancerInterventions:   Biological: bevacizumab;   Other: laboratory biomarker analysisSponsors:   Barbara Ann Karmanos Cancer Institute;   Genentech, Inc.Completed - verified March 2015

Source: ClinicalTrials.gov - July 30, 2012 Category: Research Source Type: clinical trials